Corporate Profile

Mylan Technologies Inc. (MTI) is a member of the Mylan family of companies. We are dedicated to the design, development and manufacture of transdermal drug delivery systems. We have developed a variety of generic transdermal products available for the U.S. market.

MTI was the first company to receive approval for generic Nitroglycerin, Estradiol and Fentanyl transdermal systems.

Our scientists also aided in the development of EMSAM® (selegiline transdermal system). And today, EMSAM® is manufactured by MTI.

Mylan Technologies Inc. also produces components for the medical device and transdermal industries. Our unmatched expertise, reputation for exceptional quality and ability to develop components are a catalyst for innovative and proprietary healthcare products.